Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Patrizia Pagliara

Patrizia Pagliara

Stanford University School of Medicine USA

Hamdy Abdelkader

Hamdy Abdelkader

Kingston University UK

Edgar Pérez-Herrero

Edgar Pérez-Herrero

University of Salamanca Spain

Mauricio de la Espriella Perdomo

Mauricio de la Espriella Perdomo

Cooperative University of Colombia Colombia

Ozgen Ozer

Ozgen Ozer

Turkey

Kazuo Yano

Kazuo Yano

Tokyo Women’s Medical Universit Japan

Sílvia Storpirtis

Sílvia Storpirtis

University of Sao Paulo (USP Brazil

Joana Liberal

Joana Liberal

University of Coimbra Portugal

Pharmacovigillance 2023

About the Conference

You are cordially invited to join the "16th Annual Meet on Pharmacovigilance & Drug Safety" being organized by Conference Series, which will be held in Madrid, Spain,  on May 04-05, 2023. This conference offers a platform for discussion that is focused on risk factor advancement. The improvements in pharmacovigilance, risk management, toxicology, and drug safety are the main topics. Pharmacovigilance is a rapidly expanding area, and its advancement is having a significant impact on medical research and prescribed medications. The 16th Annual Meet on Pharmacovigilance & Drug Safety underlines how the importance and significance may be determined by the fact that it has made significant progress over time and continues to have an impact on many different sectors. This year's conference will focus on "Growth & Future of Pharmacovigilance & Drug Safety."

Pharmacovigilance is expanding quickly these days, and advancements are having an effect on pharmaceutical science. The Conference series intends to deliver Detection & evaluation of medication Safety Signals, Data Quality management in light of this issue. It includes all actions related to identifying, evaluating, comprehending, controlling, and avoiding negative effects of medications on both individuals and groups.

16th Annual Pharmacovigilance and Drug Safety Meeting The year 2023 provides the best venue with its competent legal programme, which includes keynote addresses, all-hands meetings, and notice sessions on the subjects of pre-clinical and clinical trials, adverse drug reactions, pharmacovigilance and risk management, good pharmacovigilance practise, pharmacy practises and its challenges, biopharmaceutical sciences, clinical trials on various disorders, and data quality management. Entrepreneurs and Investors Convene. This is your best chance to connect with the most people in the pharmacovigilance community. Present a presentation, meet with scientists, develop a new medication, recruit speakers from around the world, and conduct clinical trials. This conference is held for two days.
PharmacovigilanceConferences2023,PharmacovigilanceMeetings,TopPharmacovigilanceConferences, PharmacovigilanceConferenceEvents, Drug Safety Conferences 2023

Target Audieance:

Pharmacologists

Business Entrepreneurs

Pharmaceutical companies.

Clinical Laboratories and Technicians

Supply Chain companies

Manufacturing Companies

Pharmaceutical Industrial Giants.

Research Institutes and members.

Students of Pharmacy

Toxicologist.

Pharmacists

Nursing Professionals

Pharmacovigilance Researchers

Pharmacovigilance Faculty

Medical Colleges

Pharmacovigilance Associations and Societies

Training Institutes

Software Developing Companies

Manufacturing Medical Devices Companies

Sessions/ Tracks

Track.1 Pharmacovigilance and Clinical Trials

Pharmacovigilance and Medical Trials will have the fast progress of new drug and innovative therapeutics, new pharmacovigilance actions and methods have to be applied for guarantee and Patient Advantage Safety Organization in Pharma, Biotech and Health Care. Clinical Traces contain the best excellence level to estimate the viability and welfare of new medications. However, in light of the fact that they are focused in homogeneous conditions a long way from this current reality of answer and use, errors in patient choice or conduct situations may change both the possibility and risks.
PharmacovigilanceConferences2023PharmacovigilanceMeetingsTopPharmacovigilance ConferencesPharmacovigilanceConferenceEventsDrug Safety Conferences 2023

Track.2. Drug Safety

The drug safety thought has got plenty of attention during the past period cheers to the very fact it plays a key role in patients’ health. Latest laws worry this idea must to be enclosed within the process of latest medications’ support and constant behavior of post-marketing drug evaluations. Advantage–risk calculation must to be imaginary of by all fitness care specialists once they ought to offer careful medication to detailed teams of patients. Therefore, additional care ought to slope to some patients, like pregnant girls, youngsters and therefore the aged, meanwhile they're thought of susceptible populations.
PharmacovigilanceConferences2023PharmacovigilanceMeetingsTopPharmacovigilance ConferencesPharmacovigilanceConferenceEventsDrug Safety Conferences 2023

Track.3. Pharmaceutical Chemistry

Pharmaceutical chemistry is the study of medicine and it includes drug improvement. This contains drug discovery, delivery, absorption, metabolism, and more. There are the basics elements of biomedical study, pharmacology, pharmacokinetics and pharmacodynamics. Pharmaceutical chemistry work is usually wiped out a laboratory setting. Pharmaceutical chemistry contains cures and remedies for disease, analytical techniques, pharmacology, metabolism, quality assurance, and drug chemistry.
PharmacovigilanceConferences2023PharmacovigilanceMeetingsTopPharmacovigilance ConferencesPharmacovigilanceConferenceEventsDrug Safety Conferences 2023

Track.4. Clinical Research and Statistics

Clinical study contains exploring deliberate medicinal behaviors, evaluating the relative benefits of good therapies, and opening optimum action combos. Clinical analysis varieties and effort to answer questions like “should a person with glandular carcinoma bear, radical ablation or radiation or wait and see?” Digits play an awfully significant role in any path from style, conduct, analysis and reportage in terms of main for and minimizing biases, clashing factors, and mensuration irregular errors.

PharmacovigilanceConferences2023PharmacovigilanceMeetingsTopPharmacovigilance ConferencesPharmacovigilanceConferenceEventsDrug Safety Conferences 2023

Track.5. Pharmacovigilance Practice                            

GVP is abbreviated as pharmacovigilance practices which is to enable to measure and presentation of Pharmacovigilance. The role of GVP and Pharmacoepidemiology in Risk Management is to raise the useful effects of a drug than its opposing effects.  The scientific trials and pharmacovigilance amenities providing companies must have Certification. It is of high rank to focus on Signal investigation via observational studies to understand safety signals.
PharmacovigilanceConferences2023PharmacovigilanceMeetingsTopPharmacovigilance ConferencesPharmacovigilanceConferenceEventsDrug Safety Conferences 2023

Track.6. Adverse Drug Reactions

These reactions are an open trial for Healthcare professionals -to know the problem and be aware of how these reactions can be stopped and managed. However, opposing drug responses can be reduced including the patient as one pillar of the healing plan and providing more patient therapy, which will recover drug safety. Evaluating and reporting adverse drug reactions are very significant to uphold drug safety systems. PK-PD studies are the two major focus areas of pharmacology.
PharmacovigilanceConferences2023PharmacovigilanceMeetingsTopPharmacovigilance ConferencesPharmacovigilanceConferenceEventsDrug Safety Conferences 2023

Track.7. Clinical Trials on Various Disorders

Clinical trials are nothing but research done in clinical study. Clinical investigation method includes a compound network of pharmaceutical companies, sites and educational study institutions/ laboratories. Each clinical trial has a strategy of action or a procedure for directing trial. Clinical trials produce data on security and efficacy. Here in these track discussions are involved in types of diseases and theirs clinical test output.
PharmacovigilanceConferences2023PharmacovigilanceMeetingsTopPharmacovigilance ConferencesPharmacovigilanceConferenceEventsDrug Safety Conferences 2023

Track.8. Pharmacy Practices and its Challenges

In Pharmacy Practices and its Trials track principally targeted on Pharmacy observe and its pointers and Trials in change of integrity and supply observe. Indefinite measure program, drug toxicity and drug safety measures place vital place in scientific study. Approaches for Growth in pharmaceutical company atmosphere are targeted in Strategic growth towards bureau support and Post marketplace product Surveillances
PharmacovigilanceConferences2023PharmacovigilanceMeetingsTopPharmacovigilance ConferencesPharmacovigilanceConferenceEventsDrug Safety Conferences 2023.

Track.9. Clinical Database Management

The field of clinical knowledge management (CDM) has recognized itself cheers to demands from every the pharmaceutical business  and therefore the preventive authorities. In the meantime the originality to “fast-track” the period of pharmaceutical product stands to rush, preventive objects have replied by needful quality-assurance values be chanced in accruing the info active in the drug analysis system.
PharmacovigilanceConferences2023PharmacovigilanceMeetingsTopPharmacovigilance ConferencesPharmacovigilanceConferenceEventsDrug Safety Conferences 2023

Track.10. Analysis of Data Quality and Management

Pharmacovigilance depends on data collected from the gathering of separate case protection reports and unlike pharmacoepidemiological information. Even the vital limits of impulsive reports, the merit of this evidence supply will be improved with smart information worth management. Though under-reporting cannot be cured this manner, the destructive impact of unfinished reports, that is another important issue in pharmacovigilance, will be abridged.
PharmacovigilanceConferences2023PharmacovigilanceMeetingsTopPharmacovigilance ConferencesPharmacovigilanceConferenceEventsDrug Safety Conferences 2023

Track.11. Drug related problems in healthcare

Pharmacotherapy has been related with undesirable health consequences such as adverse effects, interactions, adherence problems, functional decline, cognitive problems, falls, urinary incontinence and metabolic or nutritional problems6,7,8,9,10,11,12,13. The risk of these problems increases with the number of drugs. Polypharmacy, defined as the use of more than four or five drugs, occurs in 40% of the adults over 65 years old.
PharmacovigilanceConferences2023PharmacovigilanceMeetingsTopPharmacovigilance ConferencesPharmacovigilanceConferenceEventsDrug Safety Conferences 2023

Track.12. Pediatric Pharmacy

Pediatric drug experts guide children and their parents about clarification and write treatments if needed. They track their patients' therapeutic growth and safeguard that there are no harmful drug relations or unexpected side effects. Pediatric drug specialists frequently work in healing offices like specialist's offices, drug stores, and healing facilities.
PharmacovigilanceConferences2023PharmacovigilanceMeetingsTopPharmacovigilance ConferencesPharmacovigilanceConferenceEventsDrug Safety Conferences 2023

Track.13. Pharma Medicinal Chemistry

Medicinal chemistry and pharmaceutical chemistry are controls at the merging of science, mostly caused natural science, and pharmacology and unlike other organic claims to fame, where they are included with plan, complex union and growth for market of medical specialists, or bio-dynamic particles. Disclosure is the recognizable proof of novel dynamic concoction mixes, often called "hits", which are commonly found by test of mixes for a imaginary natural action.
PharmacovigilanceConferences2023PharmacovigilanceMeetingsTopPharmacovigilance ConferencesPharmacovigilanceConferenceEventsDrug Safety Conferences 2023

Track 14. Pharmacognosy and Phytochemistry

Pharmacognosy, a long settled pharmaceutical science, has assumed a various part in the disclosure, characterization, generation and institutionalization of these medications. The importance of this train regarding examination and instructing has expanded in the most recent decade as individuals from the general population in created nations have swung to the utilization of home grown solutions for the self-medicine of minor ailments. In any case, numerous phytomedicines require advance examination for their clinical adequacy, while others should be altogether researched for their potential wellbeing dangers or connections with physician recommended drugs.
PharmacovigilanceConferences2023PharmacovigilanceMeetingsTopPharmacovigilance ConferencesPharmacovigilanceConferenceEventsDrug Safety Conferences 2023

Phytochemistry is naturally huge by assuming a basic part in the plants to guard themselves against different pathogenic microorganisms by demonstrating the antimicrobial action by hindrance or executing systems. The discharge of these mixes is differing from plant to plant some deliver increasingly and some create in insignificant amount. Now and then they can be unsafe and some of the time they can be exceptionally useful.
PharmacovigilanceConferences2023PharmacovigilanceMeetingsTopPharmacovigilance ConferencesPharmacovigilanceConferenceEventsDrug Safety Conferences 2023

 

Market Analysis

According to a Grand View Research, Inc. analysis, the global pharmacovigilance (PV) market is predicted to reach USD 10.27 billion by 2025. The market is anticipated to develop at a 13.1% CAGR because The pharmacovigilance market is expanding as a result of the rising incidence of ADR.

A Grand View Research, Inc. analysis projects that the global Pharmacovigilance (PV) market would reach USD 10.27 billion by 2025. During the projected period, increasing instances of adverse drug reactions (ADRs) are anticipated to boost the market (2018 to 2025). ADRs may be caused by an increase in the use of combination medications as a result of the rise in chronic disease cases. Over the projected period, it is anticipated that this factor will increase demand for pharmacovigilance services. more nonprofit organisations Market expansion can be further fueled by organisations like the International Society of Pharmacovigilance (ISoP), which promote the advantages of PV services.


Over the course of the projection period, market expansion may be fueled by government programmes that support and encourage the usage of pharmacovigilance services. A significant amount of the overall drug consumption in hospital settings is anticipated to be accounted for by the rising usage of medications to treat chronic conditions. The demand for medications among healthcare professionals is anticipated to increase as a result of this aspect, necessitating the creation of innovative treatments through comprehensive clinical trials. Further boosting market expansion during the foreseeable period may come from expanding R&D activity at significant pharmaceutical businesses to create novel therapeutic medications.

The clinical trial phase, service provider, type, end-use, and geography can be used to segment the global pharmacovigilance (PV) market. The market can be divided into phases 1, 2, 3, and 4 of clinical trials, as well as pre-clinical. Phase 4 segment dominated the market in 2016. PV solutions provide as an additional layer of safety for medications during clinical studies. Clinical trial phase 4 is thought to be crucial since it allows for the identification of unexpected adverse medication reactions. As a result, the information tracked and gathered at this point is seen to be highly pertinent.


The market can be divided into contract outsourcing and in-house depending on the service provider. The market's dominant segment in 2016 was contract outsourcing, and in the years to come, it is expected to grow at the fastest CAGR. Over the forecast period, demand is expected to be driven by advantages associated with PV services, such as resource flexibility and reduction in fixed costs, risk, and upfront investments.

Past Conference

Conference Series LLC ltd is a renowned organization that organizes highly notable conferences is successfully affixed its “13th Global Pharmacovigilance & Clinical Trials Summit” (Global Pharmacovigilance-2019) slated during March 28-29, 2019 at Hotel Agora Moriguchi in Osaka, Japan.

Our “13th Global Pharmacovigilance & Clinical Trials Summit” was based on the theme of “Promulgating the prevention of adverse drug reaction” which has covered the below scientific sessions:

  • Clinical Research and Statistics
  • Adverse Drug Reactions
  • Causality Assessment
  • Hospital and Industrial Pharmacy
  • Clinical Trials Pharmacovigilance
  • Pharmacovigilance Significance & Scope
  •  Pharmacovigilance Practice
  • Drug Safety
  • Clinical Trial Protocols
  • Diversity in Industrial Clinical Trials and Clinical Research
  • Clinical Database Management
  • PV Consulting’s And Business opportunity
  • Bio pharmaceutics
  • Regulatory Affairs
  • Analysis of Data quality and Management
  • Entrepreneurs Investment Meet

The Conference received acknowledgments & immense support was extended by the keynote lectures mentioned below:

  • Jacob Joseph, Howard Medical School, USA
  • Ujwala Vilas Salvi, Nucleon Therapeutics LLP, Mumbai (India)
  • Chi Chen, Partner at E&Y,CHINA
  • Rajiv Joshi, Director and Assuranc. ,E &Y
  • Carole Gabay¸ DRcomGroup ,China
  • Fawad Piracha, Regeneron Pharmaceuticals, Inc ,USA

Conference Series LLC Ltd wishes to acknowledge with its deep sincere gratitude to all the supporters from the Editorial Board Members of our Open Access Journals, Keynote speakers, Valuable speakers, students, delegates for their contribution to make this event a huge success.

We once again thank you all for the enormous exquisite response. This inspires us to continue organizing events and conferences for furthering the pharmacovigilance Research. Conference Series LLC ltd therefore, is glad to announce its Annual Meet on Pharmacovigilance & Drug Safety scheduled during November 21-22, 2022 London, UK.

To Collaborate Scientific Professionals around the World

Conference Date May 04-05, 2023

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Past Conference Report

Supported By

Journal of Pharmacovigilance International Journal of Pharmacovigilance

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

exhibitor

Exhibitor

exhibitor

Exhibitor

exhibitor

Exhibitor

exhibitor

Exhibitor

mediapartner

Media Partner

Collaboration

Collaboration

Collaboration

Collaboration

Collaboration

Collaboration

mediapartner

Media Partner